328. Kat Cole, CEO of AG1
Today, I'm joined by Kat Cole, CEO of AG1. Evolving from a $160M single-SKU brand to $500M+ revenue, AG1's in hypergrowth mode — adding flavors and sleep aid AGZ, entering Costco, and investing $30M...
2 Mars 46min
Competitive Fitness, Gym-as-Clinic, Smartphone Diagnostics
February 27, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: YOU(th) Health Tech raises $4.5M to expand smartphone-based health screening platform dete...
27 Feb 2min
AI Chatbots vs Human Doctors and Trainers
February 26, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Gallup survey finds 73% of Americans turn to doctors first for health advice, with just 16...
26 Feb 3min
Oura's AI Push, Kim Kardashian's Energy Bet, Budget Gyms Upgrade
February 25, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Kim Kardashian joins UPDATE as co-founder ahead of relaunch and Walmart rollout, positioni...
25 Feb 3min
Equinox's Longevity Membership, Meta's Smartwatch, Grail's Cancer Screening
February 23, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Meta plans smartwatch launch later this year with health tracking and AI features, potenti...
24 Feb 2min
327. Sam O'Keefe, Co-Founder & CEO of Flex
Today, I'm joined by Sam O'Keefe, co-founder & CEO of Flex. Enabling use of HSA and FSA funds at checkout, Flex unlocks tax-advantaged spending on preventative health products — from fitness and rec...
23 Feb 33min
Hims buys Eucalyptus, Ergatta joins Interactive Strength, D1 Training tests the waters
February 20, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Ergatta joins Interactive Strength portfolio alongside Wattbike, CLMBR, and FORME, continu...
20 Feb 2min
Peptides, Performance Retail, and Fitness Wearables
February 19, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Andrew Huberman calls retatrutide a potential trillion-dollar drug, showing 30% weight los...
19 Feb 2min
